These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 10216166

  • 21. Mitochondrial enzyme-catalyzed oxidation and reduction reactions of stilbene estrogen.
    Thomas RD, Roy D.
    Carcinogenesis; 1995 Apr; 16(4):891-5. PubMed ID: 7728971
    [Abstract] [Full Text] [Related]

  • 22. Erythropoietin activates SIRT1 to protect human cardiomyocytes against doxorubicin-induced mitochondrial dysfunction and toxicity.
    Cui L, Guo J, Zhang Q, Yin J, Li J, Zhou W, Zhang T, Yuan H, Zhao J, Zhang L, Carmichael PL, Peng S.
    Toxicol Lett; 2017 Jun 05; 275():28-38. PubMed ID: 28456571
    [Abstract] [Full Text] [Related]

  • 23. Evidence for p53 as guardian of the cardiomyocyte mitochondrial genome following acute adriamycin treatment.
    Nithipongvanitch R, Ittarat W, Velez JM, Zhao R, St Clair DK, Oberley TD.
    J Histochem Cytochem; 2007 Jun 05; 55(6):629-39. PubMed ID: 17312011
    [Abstract] [Full Text] [Related]

  • 24. Depletion of adenine nucleotide translocator protein in heart mitochondria from doxorubicin-treated rats--relevance for mitochondrial dysfunction.
    Oliveira PJ, Wallace KB.
    Toxicology; 2006 Mar 15; 220(2-3):160-8. PubMed ID: 16427179
    [Abstract] [Full Text] [Related]

  • 25. High concentrations of stavudine impair fatty acid oxidation without depleting mitochondrial DNA in cultured rat hepatocytes.
    Igoudjil A, Massart J, Begriche K, Descatoire V, Robin MA, Fromenty B.
    Toxicol In Vitro; 2008 Jun 15; 22(4):887-98. PubMed ID: 18299183
    [Abstract] [Full Text] [Related]

  • 26. DNA biomarkers antecede semiquantitative anthracycline cardiomyopathy.
    Hahm S, Dresner HS, Podwall D, Golden M, Winiarsky R, Moosikasuwan M, Cajigas A, Steinberg JJ.
    Cancer Invest; 2003 Jun 15; 21(1):53-67. PubMed ID: 12643010
    [Abstract] [Full Text] [Related]

  • 27. The formation and persistence of carboplatin-DNA adducts in rats.
    Blommaert FA, Michael C, van Dijk-Knijnenburg HC, Schornagel JH, den Engelse L, Fichtinger-Schepman AM.
    Cancer Chemother Pharmacol; 1996 Jun 15; 38(3):273-80. PubMed ID: 8646803
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Role of exogenous melatonin in reducing the cardiotoxic effect of daunorubicin and doxorubicin in the rat.
    Dziegiel P, Jethon Z, Suder E, Sopel M, Rabczyński J, Surowiak P, Zabel M.
    Exp Toxicol Pathol; 2002 Feb 15; 53(6):433-9. PubMed ID: 11926284
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Dose-dependent increase in sensitivity to calcium-induced mitochondrial dysfunction and cardiomyocyte cell injury by doxorubicin.
    Solem LE, Heller LJ, Wallace KB.
    J Mol Cell Cardiol; 1996 May 15; 28(5):1023-32. PubMed ID: 8762040
    [Abstract] [Full Text] [Related]

  • 33. Base sequence-specific attack of stilbene estrogen metabolite(s) on the mitochondrial DNA: implications in the induction of instability in the mitochondrial genome in the kidney of Syrian hamsters.
    Thomas RD, Roy D.
    Int J Mol Med; 2001 Apr 15; 7(4):389-95. PubMed ID: 11254879
    [Abstract] [Full Text] [Related]

  • 34. Mechanism of protection of moderately diet restricted rats against doxorubicin-induced acute cardiotoxicity.
    Mitra MS, Donthamsetty S, White B, Latendresse JR, Mehendale HM.
    Toxicol Appl Pharmacol; 2007 Nov 15; 225(1):90-101. PubMed ID: 17904602
    [Abstract] [Full Text] [Related]

  • 35. The metabolism of tyramine by monoamine oxidase A/B causes oxidative damage to mitochondrial DNA.
    Hauptmann N, Grimsby J, Shih JC, Cadenas E.
    Arch Biochem Biophys; 1996 Nov 15; 335(2):295-304. PubMed ID: 8914926
    [Abstract] [Full Text] [Related]

  • 36. Increased oxidative damage to mitochondrial DNA following chronic ethanol consumption.
    Cahill A, Wang X, Hoek JB.
    Biochem Biophys Res Commun; 1997 Jun 18; 235(2):286-90. PubMed ID: 9199183
    [Abstract] [Full Text] [Related]

  • 37. Persistent alterations to the gene expression profile of the heart subsequent to chronic Doxorubicin treatment.
    Berthiaume JM, Wallace KB.
    Cardiovasc Toxicol; 2007 Jun 18; 7(3):178-91. PubMed ID: 17901561
    [Abstract] [Full Text] [Related]

  • 38. Dosimetry of O6-methylguanine in rat DNA after low-dose, chronic exposure to N-nitrosodimethylamine (NDMA). Implications for the mechanism of NDMA hepatocarcinogenesis.
    Souliotis VL, Chhabra S, Anderson LM, Kyrtopoulos SA.
    Carcinogenesis; 1995 Oct 18; 16(10):2381-7. PubMed ID: 7586139
    [Abstract] [Full Text] [Related]

  • 39. Oxidative damage in mitochondrial DNA is not extensive.
    Lim KS, Jeyaseelan K, Whiteman M, Jenner A, Halliwell B.
    Ann N Y Acad Sci; 2005 May 18; 1042():210-20. PubMed ID: 15965065
    [Abstract] [Full Text] [Related]

  • 40. Tissue-specific mtDNA lesions and radical-associated mitochondrial dysfunction in human hearts exposed to doxorubicin.
    Lebrecht D, Kokkori A, Ketelsen UP, Setzer B, Walker UA.
    J Pathol; 2005 Dec 18; 207(4):436-44. PubMed ID: 16278810
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.